KEGG: aga:AgaP_AGAP006613
STRING: 7165.AGAP006613-PB
AGAP006613 is the gene code for the Eukaryotic translation initiation factor 3 subunit J (eIF3j) in Anopheles gambiae, the African malaria mosquito. This protein is part of the eIF3 complex, which is the largest of the eukaryotic initiation factors and is involved in every step of translation initiation. The eIF3 complex participates in multiple crucial processes including recruitment of the ternary complex (TC) and mRNA to the pre-initiation complex (PIC), preventing premature association of the 40S and 60S ribosomal subunits, and modulating the fidelity of start codon selection .
In terms of biological significance, while the j subunit (eIF3j/Hcr1) is non-essential in yeast (Saccharomyces cerevisiae), it remains an important component of the conserved core complex found across organisms . Its specific role in mosquito biology may be linked to vector competence and could potentially serve as a target for novel control strategies against malaria transmission.
The shelf life of recombinant AGAP006613 depends on multiple factors including storage state, buffer ingredients, storage temperature, and the inherent stability of the protein. For optimal preservation:
For liquid formulations: Store at -20°C to -80°C with an expected shelf life of approximately 6 months.
For lyophilized formulations: Store at -20°C to -80°C with an extended shelf life of up to 12 months.
Working aliquots can be stored at 4°C for up to one week.
Repeated freezing and thawing should be avoided to maintain protein integrity .
These guidelines ensure maximum retention of structural integrity and functional activity of the recombinant protein for experimental applications.
For optimal reconstitution of lyophilized AGAP006613:
Briefly centrifuge the vial prior to opening to bring the contents to the bottom.
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.
Add glycerol to a final concentration of 5-50% (with 50% being the standard recommendation) to enhance stability during storage.
Aliquot the reconstituted protein to minimize freeze-thaw cycles.
Store the aliquots at -20°C or -80°C for long-term preservation .
This reconstitution protocol ensures that the protein maintains its structural integrity and functional properties for subsequent experimental applications.
The eIF3j subunit (AGAP006613) operates as part of the eIF3 complex, which in mosquitoes shares similarities with other eukaryotic systems but may have vector-specific characteristics. Within the translation machinery:
These dynamic interactions highlight the importance of eIF3j in the intricate process of translation initiation, though its exact role in Anopheles gambiae may differ from better-studied model organisms.
To investigate the interactions between AGAP006613 and other translation factors, researchers can employ several methodological approaches:
Co-immunoprecipitation (Co-IP): Using antibodies against AGAP006613 or tagged versions of the protein to pull down associated proteins, followed by mass spectrometry analysis to identify binding partners.
Yeast Two-Hybrid Screening: Although this system has limitations for membrane-associated proteins, it can be effective for identifying direct protein-protein interactions involving AGAP006613.
Cryo-electron microscopy (Cryo-EM): This technique has been particularly valuable for studying the structure of translation initiation complexes. Researchers have used it to visualize the positioning of eIF3 subunits, including potential locations of the j subunit, during various stages of translation initiation .
Cross-linking Mass Spectrometry (XL-MS): This approach can capture transient interactions by chemically cross-linking proteins in close proximity before analysis.
Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI): These techniques allow for real-time analysis of binding kinetics between AGAP006613 and potential interaction partners.
When designing such experiments, researchers should consider the dynamic nature of translation initiation complexes and the potential for stage-specific interactions that may be missed in static analyses.
While the search results don't provide specific data on the developmental expression pattern of AGAP006613, general principles of vector biology suggest:
Expression analysis would typically be conducted using RT-qPCR or RNA-seq techniques across egg, larval (L1-L4), pupal, and adult stages of Anopheles gambiae.
As a translation initiation factor, AGAP006613 likely shows some level of expression throughout all developmental stages, but may have particularly high expression during periods of rapid growth and development, such as during larval stages or in specific adult tissues like ovaries during egg development.
The gene appears in lists of transcripts analyzed in studies related to molecular and physiological changes in Anopheles gambiae, suggesting it may be differentially regulated under certain conditions .
Researchers investigating stage-specific expression would benefit from performing detailed temporal expression analysis using techniques that have been validated for mosquito gene expression studies, with appropriate reference genes for normalization.
AGAP006613 may represent an interesting target for vector control strategies based on several considerations:
As a component of the essential translation machinery, disruption of its function could potentially impact mosquito survival or reproduction.
The context of the search results suggests this protein might be among potential new targets in malaria vectors that could spur further research .
Novel vector control strategies are urgently needed due to widespread resistance to current insecticide classes (pyrethroids, organochlorines, organophosphates, carbamates, and DDT), which have limited modes of action targeting primarily the central nervous system .
If there are sufficient structural or functional differences between the mosquito eIF3j and human orthologs, these could potentially be exploited for selective targeting.
RNA interference (RNAi) or CRISPR-Cas9 approaches could be used to validate AGAP006613 as a control target by assessing the phenotypic effects of gene knockdown or knockout.
The development of such strategies would require thorough investigation of target validation, delivery methods, and comprehensive safety assessments to ensure specificity for the vector.
Comparative structural analysis between human and Anopheles gambiae eIF3j reveals:
Sequence alignment and structural prediction would be the first step in identifying regions of conservation and divergence between the orthologs.
Key functional domains that are conserved would likely include regions involved in binding to the 40S ribosomal subunit and other eIF3 subunits.
Regions of divergence could potentially be exploited for selective targeting by small molecules or peptides that would disrupt mosquito eIF3j function without affecting the human ortholog.
Molecular docking studies and in silico screening could identify compounds that selectively bind to unique pockets or interfaces in the mosquito protein.
Validation of structural predictions would ideally involve experimental structure determination through X-ray crystallography or cryo-EM of the Anopheles protein.
These structural differences, if significant, could form the basis for rational design of selective inhibitors as potential vector control agents with reduced risk of off-target effects in humans.
The potential involvement of AGAP006613 in mosquito immune responses to Plasmodium remains an intriguing research question:
Translation regulation is often a key component of immune responses in many organisms, and eIF3j could potentially be involved in translational reprogramming during infection.
Research methodologies to investigate this would include:
Comparing AGAP006613 expression levels between Plasmodium-infected and uninfected mosquitoes
Analyzing whether knockdown of AGAP006613 affects Plasmodium development in the mosquito
Investigating whether the protein interacts with known immune signaling pathways
If AGAP006613 plays a role in immunity, it might represent a target for strategies aimed at blocking malaria transmission by enhancing the mosquito's natural resistance to the parasite.
Advanced techniques such as ribosome profiling could reveal whether AGAP006613 contributes to selective translation of immune-related transcripts during Plasmodium infection.
This research direction connects fundamental translation machinery to vector competence, potentially offering new insights into host-parasite interactions.
When designing expression systems for AGAP006613 production, researchers should consider:
Expression Host Selection: The commercial recombinant protein is produced in yeast , which provides eukaryotic post-translational modifications. Alternative systems include:
Bacterial systems (E. coli) for high yield but potentially compromised folding
Insect cell systems (Sf9, Sf21) for more authentic post-translational modifications
Mammalian cell systems for complex proteins requiring specific modifications
Vector Design Elements:
Appropriate promoter strength for the chosen host
Signal sequences for secretion if desired
Fusion tags for purification (His, GST, MBP) that won't interfere with function
Protease cleavage sites for tag removal if necessary for functional studies
Purification Strategy:
Quality Control Metrics:
SDS-PAGE for purity assessment
Mass spectrometry for identity confirmation
Functional assays specific to eIF3j activity
These considerations ensure the production of recombinant AGAP006613 that faithfully represents the native protein's structural and functional properties for experimental applications.
To investigate the dynamic movements of eIF3j during translation initiation:
Time-resolved Cryo-EM: This technique has proven valuable for visualizing different conformational states of translation initiation complexes . By capturing samples at different time points after initiation begins, researchers can track the repositioning of eIF3j.
Single-molecule Fluorescence Resonance Energy Transfer (smFRET): By labeling eIF3j and other components of the translation machinery with fluorescent probes, researchers can observe real-time movements during the initiation process.
Cross-linking coupled with Mass Spectrometry (XL-MS): This allows detection of transient interactions by capturing proteins in close proximity at specific time points during initiation.
Structural studies comparing different initiation complexes: Research has shown that eIF3j and eIF3b may relocate to the subunit interface independently at different stages during the initiation pathway . Comparing structures from different stages can reveal these movements.
Ribosome profiling with eIF3j modifications or depletions: This can reveal how eIF3j positioning affects ribosome occupancy and translation efficiency.
These approaches, often used in combination, provide complementary information about the dynamic nature of eIF3j function during the complex process of translation initiation.